Compare WASH & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WASH | RAPT |
|---|---|---|
| Founded | 1800 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 585.9M | 498.4M |
| IPO Year | N/A | 2019 |
| Metric | WASH | RAPT |
|---|---|---|
| Price | $29.59 | $33.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $30.25 | ★ $57.00 |
| AVG Volume (30 Days) | 115.1K | ★ 440.4K |
| Earning Date | 01-28-2026 | 11-06-2025 |
| Dividend Yield | ★ 7.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $117,341,000.00 | N/A |
| Revenue This Year | $57.78 | N/A |
| Revenue Next Year | $8.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.95 | $5.67 |
| 52 Week High | $34.13 | $42.39 |
| Indicator | WASH | RAPT |
|---|---|---|
| Relative Strength Index (RSI) | 48.68 | 49.99 |
| Support Level | $30.04 | $33.01 |
| Resistance Level | $30.40 | $36.25 |
| Average True Range (ATR) | 0.51 | 2.51 |
| MACD | -0.20 | -0.34 |
| Stochastic Oscillator | 11.50 | 26.81 |
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.